Carcinosarcoma (CS) is a rare tumor, consisting of both carcinomatous and sarcomatous components. In this paper, we present a case of CS arising from a pleomorphic adenoma (PA) of the submandibular gland. A 64-year-old Japanese man presented with a left submandibular mass that had developed for 20 years with complaints of pain for the last 3 months. Magnetic resonance imaging showed a lesion involving the left submandibular gland. The patient underwent total dissection of the left submandibular gland and left cervical lymph nodes. Upon gross examination, the mass appeared completely covered by fibroadipose tissue measuring 46×42×45 mm; sectioning revealed a solid-white nodule with central bleeding and necrosis, invading into the surrounding adipose tissue. Microscopically, the presence of carcinomatous and sarcomatous components in the fibro-myxomatous stroma was detected, suggestive of pre-existing PA. The carcinoma component was diagnostic of salivary adenocarcinoma, not otherwise specified, whereas the sarcomatous component exhibited features of osteosarcoma characterized by formation of osteoid. As the border between the carcinomatous and sarcomatous components was not evident, CS may have occurred via transformation of the carcinoma into sarcoma. Tumor metastasis was detected in the cervical lymph nodes. Immunohistochemically, AE1/AE3 expression was noted in the carcinomatous component, but not in the osteosarcoma component. Both components were diffusely positive for vimentin. Four months after the operation, the patient developed a metastatic CS lesion in the lung, suggesting tumor aggression. (J Nippon Med Sch 2018; 85: 51 55) 
Introduction
Carcinosarcoma (CS) is a rare tumor, consisting of both carcinomatous and sarcomatous components. CS can arise in a variety of organs such as the skin, esophagus, lungs, uterus, and pancreas 1 5 . CS can occur in the major salivary glands, such as the parotid (65%), submandibular (22%), and sublingual (13%) glands 6, 7 . Salivary gland CS was first described by Kirklin in 1951 , and around 70 cases have been reported in the English literature to date 8 . CS accounts for 0.16 1.0% of all salivary gland tumors with a higher incidence of lymphatic and vascular invasion, and subsequent local recurrence 9, 10 . So far, the pathogenesis of salivary gland CS remains unclear. One third to one half of salivary gland CS are associated with pleomorphic adenoma (PA), also known as CS ex PA, whereas some cases present as de novo salivary gland tumors 11 14 . Herein, we present a case of CS ex PA. We performed histological and immunohistochemical analysis to illustrate the characteristics of the tumor. We further provided insights into the tumorigenesis of CS by reviewing similar cases in the literature.
Case Report
A 64-year-old Japanese man visited a local hospital with a left submandibular mass that developed over 20 years with complaints of pain over the previous 3 months (Fig.   1A ). His past medical history was unremarkable. Magnetic resonance imaging showed a heterogenous lesion in his left submandibular gland measuring up to 4.5 cm, highly suspicious of a malignant tumor (Fig. 1B) . Metastasis to several cervical lymph nodes was also suspected.
Thus, fine-needle aspiration biopsy was performed, but the result was not diagnostic. The patient was then referred to our hospital for further examination and treat- Immunohistochemical analysis showed that the carcinoma cells were AE1/AE3 positive, but negative in the sarcoma elements (arrowheads) (E). Vimentin was diffusely positive both in the carcinomatous and sarcomatous (arrowheads) components (F). Original magnification ×40 (A, B), ×200 (C F).
cles of TS-1 (a combination of tegafur, gimeracil, and oteracil, 120 mg/day). Four months following the completion of the therapy, however, a computed tomographic examination revealed a lung lesion, depicting a CS metastasis.
Discussion
CS is a rare biphasic malignant tumor consisting of both carcinomatous and sarcomatous components that can affect various organs 1 5 . The most common carcinomatous components are adenocarcinoma, followed by squamous cell carcinoma 16 . The sarcomatous components can show histological features, in decreasing order of frequency, of chondrosarcoma, fibrosarcoma, leiomyosarcoma, osteosarcoma, rhabdomyosarcoma, and liposarcoma 10,14,17 20 . In our patient, histological aspects revealed a combination of adenocarcinoma NOS and osteosarcoma. CS displays a very aggressive behavior due to its high-grade malignant potential. In the salivary gland, patients with CS have a poor prognosis because of a higher incidence of recur-rence and distant metastasis 21, 22 . In our case, the patient initially presented with lymph node metastases, and was given chemotherapy and radiation therapy after surgery. . Based on these results, they concluded that the epithelial and mesenchymal elements in salivary gland CS may have evolved from a single precursor cell. In our patient, we observed some areas in which carcinomas transitioned into sarcomas without distinct borders, suggesting that these two components are of the same origin. Although the exact underlying etiology is still elusive, we assume that it may have occurred via transformation of carcinoma into sarcoma.
In summary, a rare case of CS ex PA in the submandibular gland was described. At the initial presentation, tumor invasion occurred into the adjacent soft tissue with regional lymph node metastasis. Histologically, the carcinoma component was denoted by adenocarcinoma, NOS, whereas the sarcoma component was characterized by osteosarcoma. As the border between the carcinoma and sarcoma components was not distinct, CS was suspected to have developed due to the transformation of carcinoma into sarcoma.
